Featured Research

from universities, journals, and other organizations

Cervical cancer screening method should be changed, research suggests

Date:
April 27, 2010
Source:
Queen Mary, University of London
Summary:
Cervical cancer screening intervals could be extended to five years for women aged 30 and over if the primary screening method was human papillomavirus testing, say scientists in the UK.

Cervical cancer screening intervals could be extended to five years for women aged 30 and over if the primary screening method was human papillomavirus (HPV) testing, say scientists at Queen Mary, University of London.

The research, published in the British Journal of Cancer (28 April), found HPV tests are very accurate in identifying early signs of cervical cancer, detecting more serious abnormalities compared to current cytology screening in women aged 30 and over.

Cervical cancer affects around 2,800 women each year in the UK, and it is one of the few cancers that can be prevented through early detection of pre-cancerous cells.

One of the study's authors, John Snow Professor of Epidemiology, Jack Cuzick, said: "Using HPV testing as the primary screening method for cervical cancer would not only mean women could be screened less often but it would also mean efficiency savings for the NHS."

The study recruited more than 11,000 women from 161 family practices around the UK. Two samples were taken from each of the women; one using the conventional cytology screening method and the other was sent for HPV testing.

Results showed the women with HPV negative results had a lower rate of developing pre-cancerous (*CIN2+) cells for at least six years compared with women who recorded a negative cytology result.

Lead author, David Mesher, from the Cancer Research UK Centre for Epidemiology, Mathematics and Statistics at Queen Mary, University of London, said: "The data shows HPV testing offers improved protection from CIN2+ after a negative result compared with the protection afforded from a normal cytology result."

Professor Cuzick added: "There is now an overwhelming case for moving to HPV as the primary screening test for women 30 and over and demonstration projects should start for this now."

The research was funded by Cancer Research UK.

*Note: CIN stands for cervical intraepithelial neoplasia -- a condition of the cervix, in which abnormal cells are present on the surface of the cervix. Over time, these cells may become cancerous. CIN is classified as 1, 2 or 3, depending on its severity.


Story Source:

The above story is based on materials provided by Queen Mary, University of London. Note: Materials may be edited for content and length.


Journal Reference:

  1. D Mesher, A Szarewski, L Cadman, H Cubie, H Kitchener, D Luesley, U Menon, G Hulman, M Desai, L Ho, G Terry, A Williams, P Sasieni, J Cuzick. Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study. British Journal of Cancer, 2010; DOI: 10.1038/sj.bjc.6605619

Cite This Page:

Queen Mary, University of London. "Cervical cancer screening method should be changed, research suggests." ScienceDaily. ScienceDaily, 27 April 2010. <www.sciencedaily.com/releases/2010/04/100427220528.htm>.
Queen Mary, University of London. (2010, April 27). Cervical cancer screening method should be changed, research suggests. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/04/100427220528.htm
Queen Mary, University of London. "Cervical cancer screening method should be changed, research suggests." ScienceDaily. www.sciencedaily.com/releases/2010/04/100427220528.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins